Xu et al. [20] evaluated the transcript level of carcinoembryonic antigen (CEA), cytokeratin 19 (CK19) and cytokeratin 20 (CK20) in the peripheral blood of 168 CRC patients and 30 healthy controls. This evidence concerns the gene CEACAM5 and colorectal carcinoma.